Original Research
Published on 12 Feb 2026
CD19 exon 2 skipping is a potential prognostic correlate of anti-CD19 CAR-T therapy relapse
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2026.1763390
- 339 views
Original Research
Published on 12 Feb 2026
Original Research
Accepted on 22 Jan 2026